Copyright © 1994 by the European Society of Cardiology.
© 1994 The European Society of Cardiology
Chrome congestive heart failure
Description and survival of 190 consecutive patients with a diagnosis of chronic congestive heart failure based on clinical signs and symptoms
*Department of Cardiology, Hvidovre Hospital University of Copenhagen
Department of Clinical Physiology, Hvidovre Hospital University of Copenhagen
Department of Radiology, Hvidovre Hospital University of Copenhagen
UNI-C Arhus, Danish Computing Centre for Research and Education Denmark
Received 25 September 1992; revised 22 July 1993; .
Correspondence: Bente Kühn Madsen, Department of Cardiology 253, Hvidovre Hospital, Kettegérd Alle, DK-2650 Hvidovre, Denmark
Abstract
The prognosis, and clinical findings related to prognosis, were examined in a consecutive series of 190 patients under 76 years of age (mean 64 years) with congestive heart failure (CHF). The aetiology of CHF was ischaemic heart disease in 66%, hypertension in 11% and cardiomyopathy in 23%. The 2-year mortality was 32%. Median left ventricular ejection fraction (LVEF) was 0·30, range 0·06 to 0·74. Eight per cent were in New York Heart Association (NYHA) class I, 46% in II, 44% in III and 2% in IV.
Multivariate analysis, excluding exercise test variables, revealed seven variables with independent, significant prognostic information, (hazard ratios for death in brackets): In (natural logarithm) (LVEF) (3·19), NYHA class III+IV (2·72), plasma urea>7·6 mmol. 1–1 (2·22), serum creatinine >121 µmol. 1–1 (2·05), serum sodium <137 mmol. 1–1 (2·03), pulmonary congestion on X- ray (1·86), and age >65 years (1·86). Multivariate analysis, including exercise testing, showed the following variables to contain independent, significant prognostic information: increase in heart rate during maximal exercise 
35 min–1 (3·5), In(LVEF) (3·7), serum creatinine >121 µmol. 1–1 (2·9), maximal exercise time 4 min (2·3), serum sodium 137 mmol. 1–1 (2·5), ischaemic heart disease (2·0) and plasma urea >7·6 mmol. 1–1 (19).
In conclusion, patients with CHF have a high risk of death despite intensive medical treatment. LVEF is a strong predictor of mortality. Both NYHA class and exercise variables have strong independent prognostic information as regards mortality in combination with LVEF, but are mutually exclusive.
Key Words: Ejection fraction • exercise • congestive heart failure • functional class • prognosis
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. B. Somaratne, C. Berry, J. J.V. McMurray, K. K. Poppe, R. N. Doughty, and G. A. Whalley The prognostic significance of heart failure with preserved left ventricular ejection fraction: a literature-based meta-analysis Eur J Heart Fail, September 1, 2009; 11(9): 855 - 862. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Tonelli, N. Wiebe, B. Culleton, A. House, C. Rabbat, M. Fok, F. McAlister, and A. X. Garg Chronic Kidney Disease and Mortality Risk: A Systematic Review J. Am. Soc. Nephrol., July 1, 2006; 17(7): 2034 - 2047. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N P Nikitin, P H Loh, R de Silva, J Ghosh, O Y Khaleva, K Goode, A S Rigby, F Alamgir, A L Clark, and J G F Cleland Prognostic value of systolic mitral annular velocity measured with Doppler tissue imaging in patients with chronic heart failure caused by left ventricular systolic dysfunction Heart, June 1, 2006; 92(6): 775 - 779. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Vanholder, Z. Massy, A. Argiles, G. Spasovski, F. Verbeke, N. Lameire, and for the European Uremic Toxin Work Group (EUTox) Chronic kidney disease as cause of cardiovascular morbidity and mortality Nephrol. Dial. Transplant., June 1, 2005; 20(6): 1048 - 1056. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Bibbins-Domingo, F. Lin, E. Vittinghoff, E. Barrett-Connor, D. Grady, and M. G. Shlipak Renal insufficiency as an independent predictor of mortality among women with heart failure J. Am. Coll. Cardiol., October 19, 2004; 44(8): 1593 - 1600. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Roe-Prior Variables Predictive of Poor Postdischarge Outcomes for Hospitalized Elders in Heart Failure West J Nurs Res, August 1, 2004; 26(5): 533 - 546. [Abstract] [PDF]
|
|
|
|
|
|
V. Kirk, M. Bay, J. Parner, K. Krogsgaard, T.M. Herzog, S. Boesgaard, C. Hassager, O.W. Nielsen, J. Aldershvile, and H. Nielsen N-terminal proBNP and mortality in hospitalised patients with heart failure and preserved vs. reduced systolic function: data from the prospective Copenhagen Hospital Heart Failure Study (CHHF) Eur J Heart Fail, March 15, 2004; 6(3): 335 - 341. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Thomas, K. F. Fox, A. J.S. Coats, and G. C. Sutton The epidemiological enigma of heart failure with preserved systolic function Eur J Heart Fail, March 1, 2004; 6(2): 125 - 136. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Gustafsson, C. Torp-Pedersen, H. Burchardt, P. Buch, M. Seibaek, E. Kjoller, I. Gustafsson, L. Kober, and for the DIAMOND Study group Female sex is associated with a better long-term survival in patients hospitalized with congestive heart failure Eur. Heart J., January 2, 2004; 25(2): 129 - 135. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Meluzin, L Spinarova, L Dusek, J Toman, P Hude, and J Krejci Prognostic Importance of the Right Ventricular Function Assessed by Doppler Tissue Imaging Eur J Echocardiogr, December 1, 2003; 4(4): 262 - 271. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kittleson, S. Hurwitz, M. R. Shah, A. Nohria, E. Lewis, M. Givertz, J. Fang, J. Jarcho, G. Mudge, and L. W. Stevenson Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortality J. Am. Coll. Cardiol., June 4, 2003; 41(11): 2029 - 2035. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Gustafsson, C. Torp-Pedersen, B. Brendorp, M. Seibaek, H. Burchardt, L. Kober, and for the DIAMOND study group Long-term survival in patients hospitalized with congestive heart failure: relation to preserved and reduced left ventricular systolic function Eur. Heart J., May 1, 2003; 24(9): 863 - 870. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Vaur, P. Gueret, M. Lievre, S. Chabaud, and P. Passa Development of Congestive Heart Failure in Type 2 Diabetic Patients With Microalbuminuria or Proteinuria: Observations from the DIABHYCAR (type 2 DIABetes, Hypertension, CArdiovascular Events and Ramipril) study Diabetes Care, March 1, 2003; 26(3): 855 - 860. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. G. Mahon, E. H. Blackstone, G. S. Francis, R. C. Starling III, J. B. Young, and M. S. Lauer The prognostic value of estimated creatinine clearance alongside functional capacity in ambulatory patients with chronic congestive heart failure J. Am. Coll. Cardiol., September 18, 2002; 40(6): 1106 - 1113. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Ceia, C. Fonseca, T. Mota, H. Morais, F. Matias, A. de Sousa, A. G. Oliveira, and on behalf of the EPICA Investigators Prevalence of chronic heart failure in Southwestern Europe: the EPICA study Eur J Heart Fail, August 1, 2002; 4(4): 531 - 539. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. M. McClellan, W. D. Flanders, R. D. Langston, C. Jurkovitz, and R. Presley Anemia and Renal Insufficiency Are Independent Risk Factors for Death among Patients with Congestive Heart Failure Admitted to Community Hospitals: A Population-Based Study J. Am. Soc. Nephrol., July 1, 2002; 13(7): 1928 - 1936. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.H. McGowan, W. Martin, M.I. Burgess, G. McCurrach, S.G. Ray, T.A. McDonagh, and J.G.F. Cleland Validation of an echocardiographic wall motion index in heart failure due to ischaemic heart disease Eur J Heart Fail, December 1, 2001; 3(6): 731 - 737. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Mosterd, B Cost, A.W Hoes, M.C de Bruijne, J.W Deckers, A Hofman, and D.E Grobbee The prognosis of heart failure in the general population. The Rotterdam Study Eur. Heart J., August 1, 2001; 22(15): 1318 - 1327. [Abstract] [PDF]
|
|
|
|
|
|
O W Nielsen, J Hilden, C T Larsen, and J F Hansen Cross sectional study estimating prevalence of heart failure and left ventricular systolic dysfunction in community patients at risk Heart, August 1, 2001; 86(2): 172 - 178. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L Ryden, P.W Armstrong, J.G.F Cleland, J.D Horowitz, B.M Massie, M Packer, and P.A Poole-Wilson Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trial Eur. Heart J., December 1, 2000; 21(23): 1967 - 1978. [Abstract] [PDF]
|
|
|
|
 |
|
 K. Pardaens, J. Van Cleemput, J. Vanhaecke, and R. H. Fagard Peak Oxygen Uptake Better Predicts Outcome Than Submaximal Respiratory Data in Heart Transplant Candidates Circulation, March 14, 2000; 101(10): 1152 - 1157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Dries, D. V. Exner, M. J. Domanski, B. Greenberg, and L. W. Stevenson The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction J. Am. Coll. Cardiol., March 1, 2000; 35(3): 681 - 689. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V.G. Florea, M.Y. Henein, S.D. Anker, D.P. Francis, J.S. Chambers, P. Ponikowski, and A.J.S. Coats Prognostic value of changes over time in exercise capacity and echocardiographic measurements in patients with chronic heart failure Eur. Heart J., January 2, 2000; 21(2): 146 - 153. [Abstract] [PDF]
|
|
|
|
 |
|
 P. M. Diller, D. R. Smucker, B. David, and R. J. Graham Congestive Heart Failure Due to Diastolic or Systolic Dysfunction: Frequency and Patient Characteristics in an Ambulatory Setting Arch Fam Med, September 1, 1999; 8(5): 414 - 420. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Vasan, E. J. Benjamin, and D. Levy Congestive Heart Failure With Normal Left Ventricular Systolic Function: Clinical Approaches to the Diagnosis and Treatment of Diastolic Heart Failure Arch Intern Med, January 22, 1996; 156(2): 146 - 157. [Abstract] [PDF]
|
|